Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers (COMPARACHILLE)

July 13, 2022 updated by: Nantes University Hospital

Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers: Non-inferiority, Controlled, Randomized Trial

The importance of wearing medical compression to heal the venous ulcer has already been shown. However, no studies have been carried out on variations in medical compression tape and their impact on interface pressures which explains the lack of consensus on how to lay, including or not to include the heel. Studies on adherence to patients with medical compression have been carried out showing that one of the determining factors is comfort. The investigators therefore wish to conduct a randomized open prospective quantitative study comparing these two modes: including or not the heel .

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nantes, France
        • CHU de Nantes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients over 18 years old
  • Patient with at least one venous ulcer progressing for at least 4 weeks
  • Patient coming for a specialized outpatient consultation called "vascular wound" at Nantes University Hospital
  • Informed consent to participate in the study
  • Social security insurance affiliation

Exclusion Criteria:

  • Patients under guardianship
  • Patient with major cognitive disorders incompatible with follow-up of protocol
  • Pregnancy
  • Patient with an open leg ulcer with a Systolic Pressure Index < 0.8

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Heel included
The bandage is made by including the heel as recommended in routine.
Experimental: Heel not included
he bandage is made by leaving the heel uncovered.
The bandage is made by leaving the heel uncovered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interface pressure V3
Time Frame: 48 hours after the bandage is applied (between week 4 and week 6)

Compare the interface pressure measurements generated by a medical compression bandage between two groups of patients with open venous ulcer(s) :

  • experimental group: uncovered heel
  • control group: heel covered by the bandage.
48 hours after the bandage is applied (between week 4 and week 6)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ankle circumference
Time Frame: Day 0 and the last day (between week 4 and week 6)
Compare the evolution or appearance of an edema in the ankle. The circumference of the ankle is measured with a tape measure using a technique called the figure of 8.
Day 0 and the last day (between week 4 and week 6)
Interface pressure V2
Time Frame: 48 hours before the last visit of the protocol. (Between 4 and 6 weeks)
Compare, between the two groups, the interface pressures measured during the installation of bandage at home by the home nurse (V2 follow-up visit), compared to the recommended pressures (30-40 mmHg)
48 hours before the last visit of the protocol. (Between 4 and 6 weeks)
Interface pressure V2 and V3
Time Frame: 48 hours before the last visit of the protocol and at the last visit of the protocol (Between 4 and 6 weeks)
Compare, between the two groups, the evolution of interface pressures after 48 hours of bandage wear.
48 hours before the last visit of the protocol and at the last visit of the protocol (Between 4 and 6 weeks)
Patient satisfaction: questionnaire
Time Frame: At the last visit of the protocol (Between 4 and 6 weeks)

Between the two groups, compare patient satisfaction with a heterogeneous questionnaire.

There is no scale or score. It is asked which type of bandage the patient prefers: with or without heel included?

At the last visit of the protocol (Between 4 and 6 weeks)
Number of bandage repairs
Time Frame: Day 0
Evaluate the number of bandage repairs required to reach the recommended therapeutic pressure
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne POTTIER, CHU Nantes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 11, 2019

Primary Completion (Actual)

June 3, 2022

Study Completion (Actual)

June 3, 2022

Study Registration Dates

First Submitted

August 2, 2019

First Submitted That Met QC Criteria

August 5, 2019

First Posted (Actual)

August 6, 2019

Study Record Updates

Last Update Posted (Actual)

July 14, 2022

Last Update Submitted That Met QC Criteria

July 13, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Venous Ulcer

Clinical Trials on Heel-free bandage

3
Subscribe